These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15757009)

  • 1. Dietary supplements and stroke.
    McDonald ES; Lane JI
    Mayo Clin Proc; 2005 Mar; 80(3):315. PubMed ID: 15757009
    [No Abstract]   [Full Text] [Related]  

  • 2. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Feb; 69(28):6787-854. PubMed ID: 14968803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ephedrine alkaloids banned from dietary supplements.
    Thompson CA
    Am J Health Syst Pharm; 2004 Apr; 61(8):750-2, 756. PubMed ID: 15127956
    [No Abstract]   [Full Text] [Related]  

  • 4. Ephedrine-type alkaloid-containing dietary supplements and substance dependence.
    Miller SC; Waite C
    Psychosomatics; 2003; 44(6):508-11. PubMed ID: 14597686
    [No Abstract]   [Full Text] [Related]  

  • 5. Dietary supplements containing ephedra alkaloids.
    Traub SJ; Hoyek W; Hoffman RS
    N Engl J Med; 2001 Apr; 344(14):1096; author reply 1096-7. PubMed ID: 11291669
    [No Abstract]   [Full Text] [Related]  

  • 6. Dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk; final rule.
    Food and Drug Administration, Public Health Service, U.S. Department of Health and Human Services
    J Pain Palliat Care Pharmacother; 2004; 18(3):95-107. PubMed ID: 15364637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary supplements containing ephedra alkaloids.
    Hutchins GM
    N Engl J Med; 2001 Apr; 344(14):1095-6; author reply 1096-7. PubMed ID: 11291668
    [No Abstract]   [Full Text] [Related]  

  • 8. Cerebral vasoconstriction and stroke after use of serotonergic drugs.
    Petro DJ
    Neurology; 2002 Aug; 59(4):652; author reply 652. PubMed ID: 14746313
    [No Abstract]   [Full Text] [Related]  

  • 9. The federal ban on ephedrine dietary supplements:an important event for pain practitioners and patients.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2004; 18(3):1-4. PubMed ID: 15364627
    [No Abstract]   [Full Text] [Related]  

  • 10. Myocardial infarction associated with the use of a dietary supplement rich in ephedrine in a young athlete.
    Forte RY; Precoma-Neto D; Chiminacio Neto N; Maia F; Faria-Neto JR
    Arq Bras Cardiol; 2006 Nov; 87(5):e179-81. PubMed ID: 17396189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic stroke associated with cough and cold preparation containing methylephedrine and supplement containing Chinese herbal drugs.
    Imai N; Yagi N; Konishi T; Serizawa M; Kobari M
    Intern Med; 2010; 49(4):335-8. PubMed ID: 20154441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complicated hypertension related to the abuse of ephedrine and caffeine alkaloids.
    Berman JA; Setty A; Steiner MJ; Kaufman KR; Skotzko C
    J Addict Dis; 2006; 25(3):45-8. PubMed ID: 16956868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ephedrine-containing oral nutritional supplements in a pregnant athlete: is it worth the risk?
    Kuczkowski KM
    Acta Obstet Gynecol Scand; 2006; 85(2):247-8. PubMed ID: 16532925
    [No Abstract]   [Full Text] [Related]  

  • 14. Ephedra dangers documented.
    Health News; 2000 Dec; 6(12):6. PubMed ID: 11142943
    [No Abstract]   [Full Text] [Related]  

  • 15. Health hazards and abuse with herbal dietary supplements.
    Irby HE
    J Miss State Med Assoc; 2002 Aug; 43(8):241-3. PubMed ID: 12349838
    [No Abstract]   [Full Text] [Related]  

  • 16. JAMA patient page. Ephedra and ephedrine.
    Torpy JM; Lynm C; Glass RM
    JAMA; 2003 Mar; 289(12):1590. PubMed ID: 12672776
    [No Abstract]   [Full Text] [Related]  

  • 17. Vasospasm-induced stroke in a varsity athlete secondary to ephedrine ingestion.
    Foxford RJ; Sahlas DJ; Wingfield KA
    Clin J Sport Med; 2003 May; 13(3):183-5. PubMed ID: 12792214
    [No Abstract]   [Full Text] [Related]  

  • 18. Ephedra: once a boon, now a bane.
    Scheindlin S
    Mol Interv; 2003 Oct; 3(7):358-60. PubMed ID: 14993455
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiomyopathy associated with ephedra-containing nutritional supplements.
    Singh A; Rajeev AG; Dohrmann ML
    Congest Heart Fail; 2008; 14(2):89-90. PubMed ID: 18401217
    [No Abstract]   [Full Text] [Related]  

  • 20. Ephedrine use is risky business.
    Landry GL
    Curr Sports Med Rep; 2003 Feb; 2(1):1-2. PubMed ID: 12831669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.